Literature DB >> 41538

Pharmacokinetics of closely related benzodiazepines.

S H Curry, R Whelpton.   

Abstract

1 It is commonplace for drugs to vary by only minor chemical differences. This is particularly so for those seven benzodiazepines discussed in this paper which are related both as precursors and as metabolites. However, minor chemical differences may cause major differences in physicochemical and pharmacodynamic properties. 2 Although the physicochemical differences are difficult to relate to effect, the influence of structure on absorption, distribution and elimination is of considerable importance in governing duration of effect, as shown by studies in monkeys and in man. This in turn dictates the suitability of a particular drug as a day or night sedative, as an anticonvulsant, or as an anxiolytic. 3 Structure affects the relative potency of the compounds as anticonvulsants, anxiolytics or sedatives so that judicious choice of a particular compound for a particular patient and condition will lead to improved therapy. It is fallacious to consider all benzodiazepines as similar.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 41538      PMCID: PMC1429633          DOI: 10.1111/j.1365-2125.1979.tb00450.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Disposition of three benzodiazepines after single oral administration in man.

Authors:  M Wretlind; A Pilbrant; A Sundwall; J Vessman
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-01

2.  Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations.

Authors:  S A Kaplan; M L Jack; K Alexander; R E Weinfeld
Journal:  J Pharm Sci       Date:  1973-11       Impact factor: 3.534

3.  Study of physiological availability of temazepam in man.

Authors:  L M Fuccella; G Tosolini; E Moro; V Tamassia
Journal:  Int J Clin Pharmacol       Date:  1972-11

4.  Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline.

Authors:  G Tognoni; R Gomeni; D De Maio; G G Alberti; P Franciosi; G Scieghi
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

5.  Clinical and biochemical comparison of clorazepate and diazepam.

Authors:  A Robin; S H Curry; R Whelpton
Journal:  Psychol Med       Date:  1974-11       Impact factor: 7.723

6.  Behavioural and pharmacokinetic studies in the monkey (Macaca mulatta) with diazepam, nordiazepam and related 1,4-benzodiazepines.

Authors:  S H Curry; R Whelpton; A N Nicholson; C M Wright
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

  6 in total
  6 in total

1.  Physiological and psychological effects of clorazepate in man.

Authors:  M H Lader; S Curry; W J Baker
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

2.  Hypnotics and hangover.

Authors: 
Journal:  Br Med J       Date:  1980-03-15

Review 3.  Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-05       Impact factor: 9.546

4.  Psycho-social stress, insomnia and temazepam: a sleep laboratory evaluation in a "general practice" sample.

Authors:  M D Beary; J H Lacey; M B Crutchfield; A V Bhat
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  The neuro-endocrine impact of 3-hydroxy-diazepam (temazepam) in women.

Authors:  M D Beary; J H Lacey; A V Bhat
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  Receptor-mediated model relating anticonvulsant effect to brain levels of camazepam in the presence of its active metabolites.

Authors:  A Morino; H Sasaki; H Mukai; M Sugiyama
Journal:  J Pharmacokinet Biopharm       Date:  1986-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.